[Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?].
Larrey
Dominique
D
Service d'hépato-gastroentérologie et transplantation, Hôpital Saint-Eloi, CHU Montpellier.
D000328:Adult; D000437:Alcoholism / Q000150:complications / Q000517:prevention & control; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000090463:Iron Deficiencies; D016031:Liver Transplantation; D008297:Male; D009765:Obesity / Q000150:complications / Q000517:prevention & control; D010353:Patient Education as Topic; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D000074606:Smoking Prevention; D013997:Time Factors
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin